{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:49:18Z","timestamp":1790948958719,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.parkreldis.2007.04.004","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T07:11:59Z","timestamp":1181027519000},"page":"516-519","source":"Crossref","is-referenced-by-count":55,"title":["Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy"],"prefix":"10.1016","volume":"13","author":[{"given":"Andrew","family":"McKeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Josephs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Klos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Hecksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Bower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Michael Bostwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Eric Ahlskog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.parkreldis.2007.04.004_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archneur.62.9.noc50009","article-title":"Pathological gambling caused by drugs used to treat Parkinson disease","volume":"62","author":"Dodd","year":"2005","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.parkreldis.2007.04.004_bib2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","article-title":"Clinical features associated with impulse control disorders in Parkinson disease","volume":"67","author":"Pontone","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.parkreldis.2007.04.004_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalence of repetitive and reward-seeking behaviors in Parkinson disease","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2007.04.004_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2005.06.005","article-title":"Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy","volume":"11","author":"Klos","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.parkreldis.2007.04.004_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.20757","article-title":"Compulsive eating and weight gain related to dopamine agonist use","volume":"21","author":"Nirenberg","year":"2006","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.parkreldis.2007.04.004_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2007.04.004_bib7","first-page":"203","article-title":"Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs","volume":"75","author":"Rylander","year":"1972","journal-title":"Psychiatr Neurol Neurochir"},{"issue":"5","key":"10.1016\/j.parkreldis.2007.04.004_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/1531-8257(199909)14:5<836::AID-MDS1018>3.0.CO;2-0","article-title":"Punding on l-dopa","volume":"14","author":"Fernandez","year":"1999","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.parkreldis.2007.04.004_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/mds.20046","article-title":"Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease","volume":"19","author":"Voon","year":"2004","journal-title":"Mov Disord"},{"issue":"6289","key":"10.1016\/j.parkreldis.2007.04.004_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"issue":"2\u20133","key":"10.1016\/j.parkreldis.2007.04.004_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0014-2999(98)00896-6","article-title":"Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors","volume":"366","author":"Perachon","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.parkreldis.2007.04.004_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.parkreldis.2006.01.010","article-title":"Hypersexuality and paraphilia induced by selegiline in Parkinson's disease: report of 2 cases","volume":"12","author":"Shapiro","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2007.04.004_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.parkreldis.2003.08.002","article-title":"Stereotyped behaviors or punding after quetiapine administration in Parkinson's disease","volume":"10","author":"Miwa","year":"2004","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"10.1016\/j.parkreldis.2007.04.004_bib14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802007000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802007000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T17:22:04Z","timestamp":1546795324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802007000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1353802007000715"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2007.04.004","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}